Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Kerman

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1983
CMV and renal allograft survivalR H Kerman, R Conklin, D Cahall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
LVAD treated heart recipients do not have deleterious HLA antibodyR H. Kerman, B Radovancevic, P Przybylowski, et al.
Transplantation|December 1, 1984
The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawalS M Flechner, R H Kerman, C T Van Buren, et al.
Transplantation Proceedings|October 1, 1984
Cyclosporine improves outcome in high-risk cadaveric renal allograft recipientsC T Van Buren, S M Flechner, R H Kerman, et al.
Transplantation Proceedings|June 1, 1988
Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplantsR H Didlake, K Dreyfus, R H Kerman, et al.
Obstetrics and Gynecology|March 1, 1977
T and B cells in pregnancyM G Dodson, R H Kerman, C F Lange, et al.
The Annals of Thoracic Surgery|November 1, 1984
Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipientsR P Sterling, B B Bradley, K G Khalil, et al.
Transplantation Proceedings|March 27, 2001
Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibodyR H Kerman, S M Katz, C T Van Buren, et al.
Transplantation Proceedings|February 1, 1997
Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-respondersR H Kerman, B Susskind, S M Katz, et al.
Contributions to Nephrology|January 1, 1986
Clinical results of ciclosporin-prednisone therapy in renal transplantationB D Kahan, R H Kerman, S M Flechner, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Advances in Experimental Medicine and Biology|January 1, 1983
CMV and renal allograft survivalR H Kerman, R Conklin, D Cahall, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
LVAD treated heart recipients do not have deleterious HLA antibodyR H. Kerman, B Radovancevic, P Przybylowski, et al.
Transplantation|December 1, 1984
The use of cyclosporine in living-related renal transplantation. Donor-specific hyporesponsiveness and steroid withdrawalS M Flechner, R H Kerman, C T Van Buren, et al.
Transplantation Proceedings|October 1, 1984
Cyclosporine improves outcome in high-risk cadaveric renal allograft recipientsC T Van Buren, S M Flechner, R H Kerman, et al.
Transplantation Proceedings|June 1, 1988
Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplantsR H Didlake, K Dreyfus, R H Kerman, et al.
Obstetrics and Gynecology|March 1, 1977
T and B cells in pregnancyM G Dodson, R H Kerman, C F Lange, et al.
The Annals of Thoracic Surgery|November 1, 1984
Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipientsR P Sterling, B B Bradley, K G Khalil, et al.
Transplantation Proceedings|March 27, 2001
Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibodyR H Kerman, S M Katz, C T Van Buren, et al.
Transplantation Proceedings|February 1, 1997
Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-respondersR H Kerman, B Susskind, S M Katz, et al.
Contributions to Nephrology|January 1, 1986
Clinical results of ciclosporin-prednisone therapy in renal transplantationB D Kahan, R H Kerman, S M Flechner, et al.
Pageof 14